Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - ChromaVision Medical Sys. (NasdaqNM:CVSN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
33171 Paseo Cerveza
San Juan Capistrano, CA 92675
Phone: (888) 443-3310
Email: investorrelations@chromavision.com
Employees (last reported count): 100
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Scientific & Technical Instr.
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 59%
·Institutional: 21% (51% of float)
(68 institutions)
·Net Inst. Selling: 298.0K shares (+7.65%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Chromavision Medical Systems, Inc. develops, manufactures and markets an automated cellular imaging system (ACIS), which is designed to substantially improve the accuracy, sensitivity and reproducibility of cell imaging. Unlike manual methods of viewing and analysis, ACIS combines proprietary, color-based imaging technology with automated microscopy to assist the pathologist to rapidly make critical medical decisions. In July 1999, the FDA granted clearance for use of the ACIS system to assist the pathologist to detect, count and classify cells of clinical interest based on recognition of cellular objects of particular color, size and shape. The Company's menu of software applications for the ACIS system includes 12 tests that are commercially available and numerous additional tests that are in various stages of development.
More from Market Guide: Expanded Business Description

Financial Summary
ChromaVision Medical Systems, Inc. is a provider of automated cell-imaging systems and the manufacturer of the Automated Cellular Imaging System (ACIS). For the six months ended 6/30/01, revenues rose from $542 thousand to $1.9 million. Net loss rose 7% to $7.3 million. Net sales reflect monthly rental charges from commercial placement of the ACIS. Higher loss reflects an increase in the marketing staff and the addition of technical personnel.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Douglas Harrington, M.D., 48
Chairman, CEO
$244K$54K
Kevin O'Boyle, 45
Exec. VP-Operations, CFO
206K--  
Patricia Sisson, 47
Sr. VP of Marketing, Sales and Strategic Planning
165K--  
David Weisenthal, 51
VP, Marketing
--  --  
Kenneth Bauer, Ph.D., 50
VP and CSO
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CVSNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Dec-2000
$1.563
Recent Price$3.48 
52-Week High
on 5-Sep-2000
$14.938
Beta0.65 
Daily Volume (3-month avg)88.8K
Daily Volume (10-day avg)31.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-74.1%
52-Week Change
relative to S&P500
-65.3%
Share-Related Items
Market Capitalization$70.1M
Shares Outstanding20.1M
Float8.30M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.31 
Earnings (ttm)-$0.76 
Earnings (mrq)-$0.18 
Sales (ttm)$0.13 
Cash (mrq)$0.14 
Valuation Ratios
Price/Book (mrq)11.09 
Price/EarningsN/A 
Price/Sales (ttm)27.23 
Income Statements
Sales (ttm)$2.55M
EBITDA (ttm)-$14.7M
Income available to common (ttm)-$15.2M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-109.12%
Return on Equity (ttm)-125.57%
Financial Strength
Current Ratio (mrq)1.81 
Debt/Equity (mrq)0 
Total Cash (mrq)$2.72M
Short Interest
As of 8-Aug-2001
Shares Short759.0K
Percent of Float9.1%
Shares Short
(Prior Month)
537.0K
Short Ratio11.86 
Daily Volume64.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.